Indian pharma exports witnessed a growth of 103% since 2013-14, from Rs. 90, 415 Crores in 2013-14 to Rs. 1,83,422 Crores in 2021-22.
About:
The exports achieved in 2021-22 is the Pharma Sector’ best export performance ever.
It is a remarkable growth with exports growing by almost USD 10 billion in 8 years.
The pharma exports in 2021-22 sustained a positive growth despite the global trade disruptions and drop in demand for COVID related medicines. The trade balance continues to be in India’s favour, with a surplus of USD 15175.81 Million.
60 per cent of the world’s vaccines and 20% of generic medicines coming from India.
India ranks 3rd worldwide for production by volume and 14th by value.
Behind India’s pharma success story is our world class manufacturing excellence, robust infrastructure, cost-competitiveness, trained human capital and innovation.
The current market size of the Indian pharmaceutical industry is around USD 50 billion.
The share of pharmaceutical and drugs in our global exports is 5.92%. Formulations and biologicals continue to account for a major share of 73.31% in our total exports, followed by Bulk drugs and drug intermediates with exports of USD 4437.64 million.
India’s top 5 pharma export destinations are USA, UK, South Africa, Russia and Nigeria.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
